|Last Price||Today's Change||52-Week Range||Trading Volume|
|14.83||-0.08 (-0.54%)||14.57 - 19.37||22.7 thousand (Below Avg)|
Market data as of 2:58PM 11/24/14. Quotes are delayed by at least 15 min.
Daiichi Sankyo and Ambit Announce Results of Tender Offer
11/10/2014 7:37 PM ET
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA™ (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation
10/30/2014 8:08 PM ET